UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000044893
Receipt No. R000046614
Scientific Title Transitional vertebrae in the thoracolumbar and lumbosacral regions
Date of disclosure of the study information 2021/07/19
Last modified on 2021/07/17 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Abnormalities of vertebrae in the thoracic, lumbar and sacral vertebrae
Acronym Abnormalities of vertebrae in the thoracic, lumbar and sacral vertebrae
Scientific Title Transitional vertebrae in the thoracolumbar and lumbosacral regions
Scientific Title:Acronym Transitional vertebrae in the thoracolumbar and lumbosacral regions
Region
Japan

Condition
Condition Lumbar degenerative disease
Classification by specialty
Orthopedics
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 The aim of this study was to increase the awareness of TLTV and LSTV to reduce wrong-site surgery or diagnostic errors. Detailed knowledge of these transitional vertebrae may potentially benefit spine surgeons as well as radiologists and interventional pain medicine specialists.
Basic objectives2 Others
Basic objectives -Others The presence of transitional vertebra in the thoracolumbar and/or lumbosacral regions may cause wrong-site surgery and problems while measuring spinopelvic parameters, including pelvic incidence and lumbar lordosis. The Castellvi classification of lumbosacral transitional vertebra (LSTV) addresses coronal images but not sagittal or axial images. Therefore, it is unclear how LSTV differs from the normal lumbosacral anatomy. We aimed to investigate the lumbosacral anatomy and vertebral numbering in patients with thoracolumbar transitional vertebrae (TLTV) and/or LSTV by performing computed tomography (CT) to identify TLTVs, to number presacral vertebrae accurately and to analyze morphological differences in each LSTV type.
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Each LSTV type was examined to identify its morphological features on sagittal and axial CT images.
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Patients who underwent spinopelvic fixation
Key exclusion criteria None
Target sample size 120

Research contact person
Name of lead principal investigator
1st name Yasunori
Middle name
Last name Tatara
Organization Yokohama Minami Kyosai Hospital
Division name Spine center
Zip code 236-0037
Address 1-21-1, Mutsurahigashi, Kanazawa-ku, Yokohama
TEL 045-782-2101
Email yata20101107@gmail.com

Public contact
Name of contact person
1st name Kenichi
Middle name
Last name Takahashi
Organization Yokohama Minami Kyosai Hospital
Division name Clinical Research Center
Zip code 236-0037
Address 1-21-1, Mutsurahigashi, Kanazawa-ku, Yokohama
TEL 045-782-2101
Homepage URL
Email yata20101107@gmail.com

Sponsor
Institute Yokohama Minami Kyosai Hospital
Institute
Department

Funding Source
Organization Yokohama Minami Kyosai Hospital
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Yokohama Minami Kyosai Hospital
Address 1-21-1, Mutsurahigashi, Kanazawa-ku, Yokohama
Tel 045-782-2101
Email https://www.minamikyousai.jp/service/rinsyou.html

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2021 Year 07 Month 19 Day

Related information
URL releasing protocol https://journals.lww.com/jbjsoa/Fulltext/2021/09000/Changes_in_Lumbosacral_Anatomy_and_Vertebral.4.a
Publication of results Published

Result
URL related to results and publications https://journals.lww.com/jbjsoa/Fulltext/2021/09000/Changes_in_Lumbosacral_Anatomy_and_Vertebral.4.a
Number of participants that the trial has enrolled 124
Results LSTVs were observed in 111/880 patients (12.6%). Castellvi type III LSTVs were the most common (42/111, 37.8%), followed by S6 LSTVs (37/111, 33.3%). TLTVs were associated with LSTVs (87/111, 78.4%) and commonly identified at T13 (59/87, 67.8%).
Results date posted
2020 Year 06 Month 19 Day
Results Delayed
Results Delay Reason
Date of the first journal publication of results
2021 Year 07 Month 15 Day
Baseline Characteristics Degenerative lumbar diseases who underwent thoracolumbar fusion.
Participant flow The medical records of 880 patients who underwent thoracolumbar fusion between July 2014 and March 2020 were evaluated for TLTV and LSTV. In this study, 124 (14.1%) of 880 patients had transitional vertebrae and/or vertebral numeric variation, with a mean age (and standard deviation) of 69.7 (12.0) years and male patients accounting for 60.5% of these 124 patients.
Adverse events None
Outcome measures The anatomical location of the lowest thoracic vertebra was defined, and TLTV with dysplastic ribs was identified and classified. Each LSTV type was examined for its morphological features on sagittal and axial CT images.
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2014 Year 07 Month 01 Day
Date of IRB
2020 Year 03 Month 17 Day
Anticipated trial start date
2014 Year 07 Month 01 Day
Last follow-up date
2020 Year 02 Month 28 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information 124 patients (14.1%) were included in this study, with a mean age of 69.7 (SD 12.0) years and male patients accounting for 60.5% of the total sample.

Management information
Registered date
2021 Year 07 Month 17 Day
Last modified on
2021 Year 07 Month 17 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046614